Skip to main
XAIR

XAIR Stock Forecast & Price Target

XAIR Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Beyond Air is undergoing a leadership transition, with Robert Goodman taking over as CEO to drive commercial execution and revenue generation for the LungFit PH system, which has already shown strong traction with increasing revenue and expanding distribution. With the focus now on commercialization and expanding the platform's potential through developments such as in combination with anti-PD-1 treatment, investors can have a positive outlook on the company's growth potential and long-term success.

Bears say

Beyond Air is facing challenges in pushing US utilization and deepening hospital relationships, as well as improving execution internationally. The departures of Todd Lisi and Rob Goodman point to a shift towards a more commercially-oriented strategy. With a low number of sales reported and upcoming catalysts heavily reliant on data from ongoing Phase 1 trials, it may be difficult for the company to gain traction in the market and justify its current valuation.

XAIR has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Beyond Air Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Beyond Air Inc (XAIR) Forecast

Analysts have given XAIR a Strong Buy based on their latest research and market trends.

According to 1 analysts, XAIR has a Strong Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Beyond Air Inc (XAIR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.